Join the conversation

Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Loading...Loading...Loading...Loading...

Trending Tickers

ANT logo
Top trending tickerANT
$95.01
14.46%
#1
Anthropics high-profile IPO debut, which surged above its offering price before giving back much of the opening gain, is driving attention. Many traders call the valuation excessive and worry that early holders are selling into retail demand, while others remain bullish on Claude and Anthropics long-term AI prospects.
NBIS logo
NBIS
$98.22
8.17%
#2
Nebius is under pressure amid a broader AI and neocloud selloff, with traders pointing to data-center delivery delays, weaker growth expectations and concerns about debt and financing. Some see the decline as sector-driven and an opportunity, while bears question Nebiuss execution and ability to fund its buildout.
AMD logo
AMD
$483.36
8.82%
#3
A Hunterbrook short report alleging AMD firmware reached a blacklisted Chinese server maker and raising export-control concerns has driven heavy selling. Traders are divided between fears of regulatory scrutiny and claims the report is unproven or self-interested, while AMD says it complies with U.S. export rules and that the report misrepresents its practices.
BABA logo
BABA
$83.94
0.51%
#4
Alibabas quarterly results have sparked debate: traders point to strong AI-cloud growth and improved e-commerce profitability, while the adjusted earnings miss, heavier AI infrastructure spending and weaker free cash flow weigh on sentiment. Fresh U.S. chip and data-center restrictions add concern about growth prospects, even as bulls call the shares undervalued and bears focus on the prolonged selloff.
GME logo
GME
$27.22
2.60%
#5
Roaring Kittys return to X has revived speculation about renewed GameStop momentum and a possible squeeze, with traders looking for a follow-up or position disclosure. Reactions are divided: some expect the post to bring buyers back, while others say the stocks muted move shows it has limited impact; Trumps disclosed small buy-in is also being mentioned.
IREN logo
IREN
$14.46
5.15%
#6
IREN is drawing attention amid a sharp, extended selloff in neocloud and AI-infrastructure stocks, with traders citing sector-wide risk aversion and concerns about funding needs, potential dilution, and project execution. The community is split between bargain hunters expecting a rebound and bears who see further downside; hopes that Anthropic-related momentum or a customer deal could help remain speculative.
QQQ logo
QQQ
$646.66
1.95%
#7
A sharp Nasdaq and tech-stock selloff, with an early rally reversing into heavy selling, dominates the discussion; traders variously blame the Anthropic IPO and renewed AI-bubble concerns, though that connection is speculative. The community is split between expecting more downside and viewing the volatility as an oversold dip or potential bottom.
KLAR logo
KLAR
$12.78
11.56%
#8
Klarnas Q3 results and outlook have driven a volatile selloff, with traders concerned about slowing growth, profitability and forward guidance despite reported operating progress. The community is split between those calling the quarter solid and buying the pullback, and bearish traders pointing to the sharp drop and Morgan Stanleys downgrade citing business complexity and uneven growth.
CAPR logo
CAPR
$7.62
5.11%
#9
Attention centers on the FDAs pending PDUFA decision for Capricors deramiocel for Duchenne muscular dystrophy, with discussion focused on whether the applications upper-limb indication will be approved or receive a CRL. Traders are sharply divided, while volatile price moves fuel unverified speculation about leaks, short selling, and positioning ahead of the binary decision.
SVRA logo
SVRA
$5.16
9.22%
#10
Savara is drawing attention ahead of the FDAs decision on MOLBREEVI for autoimmune PAP, which could become the first approved drug therapy for the rare lung disease. Traders are split on the binary outcome: bulls point to positive Phase 3 data and the FDAs extension without citing safety, efficacy, or manufacturing concerns, while skeptics remain wary of the prior filing issues and regulatory delay; short-covering is also part of the discussion.

About Stocktwits

With over 10 million users, Stocktwits helps you tap into the real-time sentiment and trending insights across stocks, ETFs, and crypto.